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Abstract Background: We analyzed the health-related quality of life (HRQOL) and its determinants in the
first year after laparoscopic adjustable gastric banding (LAGB). The setting was 10 Italian public
and private bariatric surgery centers.
Methods: Data collected in an ongoing, prospective, 3-year multicenter Italian study on the changes in
HRQOL after LAGB were used. HRQOL was investigated using the Medical Outcomes Study Short-
Form 36 questionnaire. Hunger, satiety, and the self-perceived effects of LAGB were recorded.
Results: A total of 334 patients were enrolled. The follow-up rate was 92.2%. The percentage of
excess weight loss was 39.6%  25.8%, with very few side effects or complications. Hunger in the
morning (0–10 scale) was 4.5  2.7 before surgery and 3.8  2.4 after 1 year (P .001). Satiety
after a meal (0–10 scale) was 7.1  2.7 before surgery and 8.2  1.9 at 1 year (P .001). The
self-perceived effect of LAGB on caloric intake (0–10 scale) was 8.4  1.9 after 1 year. The scores
for the 8 Medical Outcomes Study Short-Form 36 subscales were significantly improved after
surgery. The physical component summary score was 52.6  11.9 at baseline and 79.1  15.6 after
1 year (P .001). The corresponding mental component summary scores were 52.2  12.3 and
76.5  17.2 (P .001). Greater physical component summary improvement was independently
associated with a low initial physical component summary (P.001), high satiety (P .002), a high
percentage of excess weight loss (P  .013), and a high self-perceived effect of the LAGB (P 
.026). Greater mental component summary improvement was associated with a low initial mental
component summary (P .001), high satiety (P .001), a low frequency of heartburn (P  .004),
and a high percentage of excess weight loss (P  .012).
Conclusions: Significant improvements in HRQOL were observed in the first year after LAGB. A
poor baseline HRQOL, a high efficacy of the banding in eating control, and better weight loss might
influence HRQOL changes. (Surg Obes Relat Dis 2012;8:260–268.) © 2012 American Society for
Metabolic and Bariatric Surgery. All rights reserved.
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doi:10.1016/j.soard.2011.12.012Laparoscopic adjustable gastric banding (LAGB) is one of the
most frequently performed procedures worldwide [1]. LAGB has
been proved to be associated with successful weight loss and
weight maintenance [2,3], improvement of obesity-related co-
morbidities [2,4], and reduced all-cause mortality [5,6]. Initial
observations also reported an improvement in health-related qual-
ity of life (HRQOL) after LAGB [7–11].
Bariatric Surgery. All rights reserved.
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261Quality of Life After Gastric Banding / Surgery for Obesity and Related Diseases 8 (2012) 260–268Several studies investigating HRQOL in morbid obese
candidates for bariatric surgery uniformly confirmed that
these patients have HRQOL levels significantly lower than
the corresponding national norms [8,9,12–16]. HRQOL is a
complex item and refers to the overall effects of medical
conditions on physical, mental, and social functioning and
well-being, as subjectively evaluated and reported by the
patient [17]. The entity of the impairment of HRQOL in
bese patients has been found to be related to obesity levels
18] but is also influenced by the presence of somatic
omplaints and co-morbidities [16,19,20], mental disorders
[20,21], and unfavorable socioeconomic factors [22,23].
The entity of the improvement in HRQOL observed after
LAGB might be only partly explained by the degree of
weight loss [7,10,11], and it might also be influenced by
reoperative co-morbidities [7] and the interval after sur-
gery [10]. However, LAGB can also cause adverse upper
gastrointestinal side effects in some patients [24]. The rel-
ative weight of these symptoms (an inability to consume
solid foods, moderate dysphagia, occasional regurgitation)
on overall patient satisfaction has been reported to be low in
a cross-sectional analysis of obese subjects treated with
LAGB [24]. However, the role of gastrointestinal side ef-
ects in determining postoperative HRQOL after LAGB has
ever been prospectively analyzed.
The objective of our study, therefore, was to prospec-
ively analyze the weight loss, rates of complications and
pper gastrointestinal side effects, and changes in HRQOL
n the first year after surgery in a large series of morbidly
bese patients enrolled in a prospective 3-year multicenter
talian study on the changes in HRQOL in patients treated
ith LAGB. In the present study, HRQOL was analyzed
sing the 36-item Medical Outcomes Study Short-Form
ealth Survey (SF-36) questionnaire.
ethods
atients and procedures
The Italian Group for Lap-Band (Gruppo Italiano Lap-
and [GILBPLUS]) is a centralized electronic database that
ollects operative and follow-up data from Italian surgical
enters using the Lap-Band System (Allergan Medical, Ir-
ine, CA) as a LAGB procedure. Participation of the centers
o the database is voluntary. In 2008, GILBPLUS designed
n ongoing prospective 3-year observational study on the
hanges in HRQOL in patients treated with LAGB. Partic-
pation of the GILBPLUS centers in the present study was
n a voluntary basis, and participating centers agreed to
omply with a minimal follow-up rate of 75% to maintain
heir right to participate. The general design of the study and
aseline data have been previously described [25]. In brief,
the inclusion and exclusion criteria were in accordance with
standard international guidelines for bariatric surgery
[26,27]. From June 2008 to December 2009, 383 morbidlyobese candidates for LAGB (82 men and 301 women) were
originally enrolled in 13 Italian bariatric surgery centers
participating in the GILBPLUS study and underwent LAGB
surgery [25]. Each patient gave written informed consent for
study participation. Two centers were subsequently ex-
cluded from the study because of an inability to provide
acceptable follow-up rates. Also, 1 center withdrew its par-
ticipation for personal reasons. Finally, 334 participants (74
men and 260 women) were enrolled at 10 Italian bariatric
surgery centers. Their mean age was 38.9  10.1 years
(range 19–60), and they had a mean body mass index
(BMI) of 41.7  5.6 kg/m2 (range 35.0–77.0). No signifi-
cant differences were found in the baseline characteristics of
the patients finally included in the study or in the excluded
patients (data not shown). Only data collected during the
first year of the study were used in the present report.
A preoperative multidisciplinary assessment was per-
formed at all centers. The basic multidisciplinary assess-
ment included clinical history, physical examination, psy-
chological evaluation, blood tests, electrocardiography,
chest radiology, spirometry, abdominal ultrasonography,
and esophagogastroduodenoscopy. Additional tests and
consultations were scheduled if clinically appropriate. All
clinical data were electronically stored in a centralized elec-
tronic database.
All LAGB procedures were performed on an inpatient
basis using the LAP-BAND AP Adjustable Gastric Banding
System (Allergan Medical, Irvine, CA). At discharge, the
patients were instructed to follow a modified liquid diet for
4 weeks. Thereafter, a solid diet was followed, with an
inventory of permitted foods and a list of rules specifically
developed for patients with gastric restriction. Both the
liquid and solid diets were arranged to fit a 24-hour energy
intake of 2.5 MJ (40% protein. 25% fat, 35% carbohydrate).
Physical activity was encouraged. Patients were seen on an
outpatient basis 1, 3, 6, and 12 months postoperatively and
yearly thereafter. Band adjustments were performed with
the barium swallow test under fluoroscopy and the levels of
band filling were recorded as the volume of saline solution
progressively inflated into the band after surgery.
No further efforts for the standardization of patient care
management among participating centers were made for the
specific purpose of the present study. However, both pre-
operative and perioperative clinical pathways and surgical
technique were relatively uniform among the GILBPLUS
centers.
Study measurements
The study measurements were performed at baseline and
6 and 12 months after surgery.
All anthropometric measurements were made with the
subjects wearing only light clothes without shoes. Height
was measured to the nearest .01 m using a wall-mounted
stadiometer. The body weight was determined to the nearest
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262 V. Pilone et al. / Surgery for Obesity and Related Diseases 8 (2012) 260–268.05 kg using a calibrated balance beam scale. The BMI was
calculated as the weight in kilograms divided by the height
in meters squared. The systolic and diastolic blood pressure
were measured with the patient in the sitting position, after
a 5-minute rest, with an appropriately sized cuff. Venous
blood sampling was drawn early in the morning, after a
12-hour overnight fast. The fasting blood glucose, glycated
hemoglobin, total cholesterol, high-density lipoprotein cho-
lesterol, triglycerides, and the liver enzymes aspartate
transaminase and alanine transaminase were determined us-
ing standard methods by local laboratories.
Specific questions about preoperative co-morbidities
were included in the GILBPLUS database. Diabetes was
defined as a fasting plasma glucose level of 126 mg/dL or
the use of any antidiabetic drug [28]. Hypertriglyceridemia
was defined as fasting triglycerides of150 mg/dL and low
high-density lipoprotein as a high-density lipoprotein cho-
lesterol level of 40 mg/dL in men and 30 mg/dL in
omen [29]. Hypertension wad defined as blood pressure
140/90 mm Hg or the use of any antihypertensive drug
30]. Sleep apnea was diagnosed on the basis of the pres-
nce of subjective diurnal and/or nocturnal symptoms [31].
n instrumental registration of the breathing pattern during
leep was not mandatory. Osteoarthritis was clinically de-
ned as the presence of chronic pain in the weight-bearing
oints with or without the use of pain suppressant medica-
ions. As a part of the preoperative multidisciplinary assess-
ent, eating behavior disorders, eating attitudes, and psy-
hological symptoms were evaluated in all patients during a
linical unstructured interview performed by an experienced
sychologist. Psychiatric consultation was not routinely
erformed, but it was requested in the case of suspected
evere psychiatric co-morbidity. Patients with psychotic
isorders, severe depression, and personality disorders were
xcluded [26]. Patients with a mild-to-moderate major de-
ressive disorder or dysthymic disorder were included and
imply categorized as affected by depression. The diagnosis
f binge eating disorder was determined using standard
iagnostic criteria [32]. Sweet eating was diagnosed when
he patient craved simple carbohydrates, and carbohydrate
raving could be continuously present or triggered by emo-
ional (anxiety, stress) or physiologic (premenstrual phase)
ituations [33]. Nibbling was diagnosed when the patient ate
mall quantities of foods repetitively between meals, typi-
ally triggered by inactivity and/or loneliness [33].
Hunger in the morning after an overnight fast and satiety
fter a standard meal were graded by the patients using a
–10 visual scale before and 6 and 12 months after surgery.
t the 2 postoperative evaluations, the patients were also
sked to rate the self-perceived effect of LAGB on their
aloric intake using a 0–10 visual scale. The gastrointestinal
ymptoms were recorded with the use of a standardized
rief questionnaire. Dysphagia, simply defined as difficultly
wallowing any type of food, and reflux were categorized as
bsent or present. The frequency of episodes of food regur- witation during meals was categorized using a 0–3 scale (0, no
pisodes of vomiting during the previous month; 1, no 5
pisodes of vomiting during the previous month; 2, no than
0 episodes of vomiting during the previous month; 3, 20
pisodes of vomiting during the previous month or daily vom-
ting) [34]. The frequency of heartburn or gastric pyrosis epi-
odes were categorized using a similar 0–3 scale.
HRQOL was analyzed using the SF-36 questionnaire.
he standard (4-wk) recall, version 2.0, of the SF-36 was
sed. The SF-36 measures the following 8 subscales: phys-
cal functioning, social functioning, role limitations due to a
hysical problem, role limitations due to an emotional prob-
em, mental health, vitality, bodily pain, and general health
erception. The 8 subscales form 2 distinct higher ordered
ummary scales: the physical component summary scale
PCS), mainly based on physical functioning, role limita-
ions due to a physical problem, pain, and general health
erception; and the mental summary component scale
MCS), mainly reflecting social functioning, role limitations
ue to an emotional problem, mental health, and vitality
35]. The SF-36 has an Italian validated version, and nor-
ative values have been published for the Italian adult
opulation [36].
tatistical analysis
All statistical analyses were performed using the Statistical
ackage for Social Sciences, version 18.0 (SPSS, Chicago, IL).
n all analyses, P.05 was considered statistically significant.
he frequencies, mean values, and standard deviations were
sed to describe the baseline characteristics of the patients.
ifferences in the values observed before and after surgery
ere evaluated using a paired Student’s t test. Changes in
RQOL were quantified as the difference between the values
f the 2 SF-36 summary scales (PCS and MCS) observed 12
onths after surgery and those observed at baseline. The de-
erminants of PCS and MCS changes were first analyzed by
imple correlation analysis. Categorical covariates was coded
s absent (0) or present (1). The tested variables were gender
0male; 1 female), age at surgery, baseline BMI, baseline
CS and MCS scores, baseline physical co-morbidities (type 2
iabetes, hypertension, sleep apnea, osteoarthritis), baseline
epression and eating behavior disorders (binge eating disor-
er, sweet eating, nibbling), resolution of physical co-morbid-
ties at 12 months, dysphagia and reflux at 12 months, regur-
itation and pyrosis scores at 12 months, morning hunger and
fter meal satiety at 12 months, self-perceived effect of LAGB
n caloric intake at 12 months, BMI, and percentage of excess
eight loss (%EWL) level at 12 months. Variables signifi-
antly associated with changes in the PCS or MCS scores on
imple correlation analysis were finally entered in a stepwise
ultiple linear regression model to test their independent con-
ribution to the variability of PCS or MCS changes. Predictors
ere selected at a significance level of P .05. As a criterion
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263Quality of Life After Gastric Banding / Surgery for Obesity and Related Diseases 8 (2012) 260–268for removing variables in the stepwise regression, P for F of
.10 was chosen.
Results
The baseline characteristics of the 334 morbid obese
participants in the GILBPLUS prospective 3-year observa-
tional study on the changes of HRQOL in patients treated
with LAGB are reported in Table 1. Our series included
mainly young female patients with a relatively low BMI and
co-morbidity burden. All but 1 surgical procedures were
performed using a laparoscopic approach. The LAP-BAND
AP was successfully positioned in all patients (AP small in
67.7% and AP large in 32.3%), with no perioperative mor-
tality. Intraoperative complications were mild and rare
(2.1%), and only 3 patients (.9%) presented with early
postoperative medical or surgical complications. The mean
operative time was 67.8  33.1 minutes (range 20–240),
and the mean hospital stay was 2.7  3.8 days (range 1–9).
The anthropometric and biochemical data collected in
the first year after surgery are reported in Table 2. The
follow-up rate was 97.0% at 6 months (324 patients) and
92.2% at 12 months (308 patients). The %EWL was
29.2%  15.9% at 6 months and 39.6%  25.8% at 12
months. During the first year after surgery, 2 cases of pouch
dilation (.6%) were observed, 1 of which evolved to slip-
page requiring band removal (.3%). No case of band erosion
or infection was observed, and no additional band-related
redo surgery was required. Five minor port complications
were observed (1 port-tube leak, 3 port rotations, and 1 port
infection), and 2 patients (.6%) required minor port-related
surgery. One female patient became pregnant during the
first year after surgery. The fasting blood glucose, total
cholesterol, low-density lipoprotein cholesterol, triglycer-
ides, and alanine transaminase levels were significantly re-
Table 1
Baseline characteristics of 334 morbidly obese patients
Baseline characteristic Value
Male gender (%) 22.2
Age (yr) 38.9  10.1
Body weight (kg) 113.8  18.6
BMI (kg/m2) 41.7  5.6
Type 2 diabetes (%) 11.4
Hypertriglyceridemia (%) 11.1
Low HDL levels (%) 8.1
Hypertension (%) 27.5
Sleep apnea (%) 9.3
Osteoarthritis (%) 21.6
Binge eating (%) 3.9
Sweet eating (%) .6%
Nibbling (%) 11.7
Depressive symptoms (%) 8.4
BMI  body mass index; HDL  high-density lipoprotein.
Data presented as mean  standard deviation or percentages.duced at the 6-month evaluation and remained substantiallystable afterward. The glycated hemoglobin level in patients
with type 2 diabetes at baseline was 6.3%  1.2% before
surgery and 5.2%  .9% at 6 months (P .001) and
5.5% .7% at 12 months (P .05) after surgery. The
resolution of type 2 diabetes was observed in 79.4% of
patients at 6 months and 85.3% at 12 months. The resolution
of hypertension was observed in 77.3% of the patients at 6
months and 89.2% at 12 months postoperatively. Symptoms
of sleep apnea had disappeared in 96.6% of patients at 6
months and 100.0% of patients at 12 months. Pain related to
osteoarthritis had disappeared in 80.9% of patients at 6
months and 87.3% at 12 months.
Hunger in the morning after an overnight fast, satiety
after a standard meal, the self-perceived effect of LAGB on
caloric intake, and the band filling levels are reported in
Table 3. Hunger in the morning after an overnight fast was
graded as significantly reduced by the patients after surgery
and satiety after a standard meal significantly increased.
Patients graded the self-perceived effect of LAGB on ca-
loric intake as high after surgery (8 on a 0–10 visual scale).
The self-perceived effect of LAGB was found to strongly
correlate with satiety after a meal at both 6
(r  .522; P .001) and 12 (r  .501; P .001) months.
The self-perceived effect of LAGB correlated negatively
with hunger in the morning at both 6 (r  .216; P .001)
and 12 (r  .143; P .05) months. Moderate correlation
levels were found between the self-perceived effect of
LAGB and the %EWL (r  .132; P .05 at 6 mo; and r 
.166; P .01 at 12 mo). No significant correlations were
Table 2
Anthropometric and biochemical data in first year
Variable Baseline 6 mo 12 mo
Patients (n) 334 324 (97.0) 308 (92.2)
Body weight (kg) 113.8  18.6 97.6  17.5* 93.4  17.9*†
Body mass index
(kg/m2)
41.7  5.6 35.8  5.5* 34.3  5.7*†
EWL (%) — 29.2  15.9 39.6  25.8†
asting blood glucose
(mg/dL)
94.0  18.0 89.4  13.5‡ 89.7  13.9‡
bA1c (%) 5.1  1.1 4.9  .8 5.0  .7
otal cholesterol (mg/
dL)
200.8  39.5 188.6  36.7* 184.9  37.2*
DL cholesterol (mg/
dL)
47.0  10.9 43.2  10.0§ 43.3  11.6
DL cholesterol (mg/
dL)
122.6  35.4 118.0  34.6‡ 115.2  33.0‡
riglycerides (mg/dL) 155.5  74.4 134.7  39.9* 129.2  39.8*
ST (U/L) 23.9  12.4 24.1  8.7 22.3  8.3
LT (U/L) 30.3  22.3 24.6  10.1‡ 23.1  9.7‡
HDL high density lipoproteins; LDL low density lipoproteins; AST
spartate transaminase; ALT  alanine transaminase.
Data presented as numbers, with percentages in parentheses, or mean 
tandard deviation.
* P .001, paired Student’s t test versus baseline.
† P .001, paired Student’s t test versus 6 months.
‡ P .01, paired Student’s t test versus baseline.
§ P .05, paired Student’s t test versus baseline.
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264 V. Pilone et al. / Surgery for Obesity and Related Diseases 8 (2012) 260–268found between the levels of band filling volume and hunger,
satiety, or self-perceived effect of the band at any point after
surgery. The levels of band filling volume correlated nega-
tively with the %EWL at both 6 (r  .300; P .001) and
2 (r  .256; P .001) months.
The frequency of episodes of food regurgitation during
eals and episodes of heartburn or gastric pyrosis are
hown in Figure 1. No significant increases in the frequency
f episodes of heartburn or gastric pyrosis were observed
fter surgery. In contrast, the frequency of episodes of
egurgitation of food during meals significantly increased
fter surgery, at both 6 (P.001) and 12 (P.001) months.
t the 6-month evaluation, 34.4% of the patients had no
pisodes of food regurgitation during the previous month,
9.5% had 5 episodes, 12.9% had 20 episodes, and
Table 3
Hunger morning after overnight fast, satiety after standard meal, self-
perceived effect of gastric banding on caloric intake, and band filling
levels in first year
Variable Baseline 6 mo 12 mo
atients (n) 334 324 (97.0) 308 (92.2)
unger in morning 4.5  2.7 4.0  2.4* 3.8  2.4†‡
Satiety after meal 7.1  2.7 7.9  2.1† 8.2  1.9†§
Self-perceived effect of LAGB — 8.0 2.1 8.4  1.9¶
Band filling volume (mL) .0 .0 3.6  2.1† 4.5  2.3†¶
LAGB  laparoscopic adjustable gastric banding.
Data presented as numbers, with percentages in parentheses, or mean 
standard deviation.
* P .01, paired Student’s t test versus baseline.
† P .001, paired Student’s t test versus baseline.
‡ P .05, paired Student’s t test versus 6 months.
§ P .01, paired Student’s t test versus 6 months.
¶ P .001, paired Student’s t test versus 6 months.
Fig. 1. Frequencies of episodes of food regurgitation during meals and
episodes of heartburn or gastric pyrosis in first year of Italian Group for
Lap-Band (GILBPLUS) prospective 3-year observational study on changes
of HRQOL after LAGB: 334 participants enrolled in 10 Italian bariatric
surgery centers. Follow-up rate was 97.0% at 6 months (324 patients) and
92.2% at 12 months (308 patients). Frequencies were categorized on a 0–3
scale (0, no episodes during previous month; 1, 5 episodes during
previous month; 2, 20 episodes during previous month; and 3, 20eepisodes during previous month or daily episodes)..2% had 20 episodes or daily food regurgitation. At the
2-month evaluation, 39.1% of the patients had no episodes,
5.0% had 5 episodes, 11.9% had 20 episodes, and
.0% had 20 episodes or daily food regurgitation. No
ignificant interactions were found between the frequency
f food regurgitation after surgery and the levels of hunger
n the morning, satiety after a meal, self-perceived effect of
AGB on caloric intake, band filling levels, and %EWL
data not shown). A very small fraction of patients reported
aving dysphagia (1.5% at 6 mo and 2.0% at 12 mo) or
eflux (2.0% at 6 mo and .3% at 12 mo) after surgery.
The HRQOL levels before and after LAGB are shown in
igure 2. Before surgery, the scores for the 8 SF-36 subscales
ere lower than those for the general adult Italian population.
ompared with the baseline values, highly significant im-
rovement (P.001) was observed in all 8 SF-36 subscales at
he 6-month evaluation. Compared with the 6-month values, an
dditional significant improvement in HRQOL levels was ob-
erved at the 12-month evaluation for physical functioning
P .001), bodily pain (P .001), general health (P .001),
itality (P .05), social functioning (P .01), and role limi-
ations due to an emotional problem (P .01). The physical
CS was 52.6  11.9 at baseline, 75.3  19.9 at 6 months
P .001), and 79.1  15.6 at 12 months (P .001 versus
aseline and P.001 versus 6 mo). The MCS was 52.2 12.3
t baseline, 73.2  18.2 at 6 months (P .001), and 76.5 
7.2 at 12 months (P .001 versus baseline and P .001
ersus 6 mo).
Changes in HRQOL have been calculated as the differ-
Fig. 2. Health-related quality of life (HRQOL) levels in the first year of
the Italian Group for Lap-Band (GILBPLUS) prospective 3-year obser-
vational study on the changes of HRQOL after laparoscopic adjustable
gastric banding: total of 334 participants enrolled in 10 Italian bariatric
surgery centers. Follow-up rate was 97.0% at 6 months (324 patients)
and 92.2% at 12 months (308 patients). Baseline (white bars), 6-month
(gray bars), and 12-month (black bars) HRQOL levels reported. Eight
subscales of SF-36 questionnaire indicated: PF  physical functioning;
RP  role limitations due to physical problem; BP  bodily pain;
H  general health; VT  vitality; SF  social functioning; RE 
ole limitations due to an emotional problem; MH  mental health.
lack line represents normative values in Italian adult population [36].nce between the PCS and MCS values observed 12 months
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value was found in 94.3% of the patients for PCS and 91.6%
for MCS. Determinants of PCS and MCS changes were
analyzed by simple correlation analysis. The variables
tested have been reported in the “Statistical Analysis” sec-
tion, and the variables significantly associated with changes
in the PCS or MCS scores are reported in Table 4. Improve-
ents in both summary scales were more relevant in pa-
ients with poor HRQOL at baseline. Moderate levels of
orrelation were found between the PCS and MCS changes
nd the degree of weight loss (%EWL). Satiety after a
tandard meal and the self-perceived effect of LAGB on
aloric intake were positively associated with both PCS and
CS changes after surgery. Finally, a negative correlation
etween the frequency of gastric pyrosis at 12 months and
he change in MCS was observed. The independent contri-
ution to these variables to the variability in PCS or MCS
hanges was tested in a stepwise multiple linear regression
odel analysis. High improvements in PCS were indepen-
ently associated with low baseline PCS levels (P  .000),
high satiety after a meal (P  .002), high %EWL (P 
.013), and high self-perceived effect of LAGB (P  .026).
High improvements in MCS were independently associated
with low baseline MCS levels (P  .000), high satiety after
a meal (P  .000), a low frequency of gastric pyrosis (P 
.004), and a high %EWL (P  .012). However, our model
explained only a moderate fraction of the PCS and MCS
change variability. The explained variance was 27.6% for
PCS change variability and 22.9% for MCS change vari-
ability.
Discussion
In the present study, we analyzed the changes in self-
Table 4
Variables significantly associated with changes in physical component
summary score and mental component summary score in first year after
surgery
Variable Change in
PCS
Change in
MCS
Baseline PCS score .423* .154†
Baseline MCS score .245* .324*
Frequency of gastric pyrosis at 12 mo — .126‡
Satiety after meal at 12 mo .168† .210*
Self-perceived effect of band at 12 mo .199† .191†
Excess weight loss at 12 mo (%) .125‡ .129‡
PCS  physical component summary; MCS  mental component sum-
mary.
Simple linear correlations coefficients reported.
Changes in PCS and MCS calculated as difference between 12-month
values and baseline values; variables tested reported in “Statistical Anal-
ysis” section.
* P .001.
† P .01.
‡ P .05.reported HRQOL in the first year after surgery in a largegroup of morbidly obese patients enrolled in a multicenter
prospective study of the changes in HRQOL in patients
treated with LAGB. We have confirmed previous observa-
tions reporting a significant improvement in HRQOL [7–
11]. The improvement in HRQOL was greater in patients
with a poor level of HRQOL before surgery and in patients
with greater weight loss after surgery. We also confirmed
that LAGB is not only able to increase satiety after meal, but
also to reduce hunger after an overnight fast. Patients graded
as high (8 on an 0–10 scale) the effect of LAGB on their
caloric intake. High satiety after meal and a high self-
perceived effect of the banding on caloric intake were both
associated with greater improvement in HRQOL in the first
year after surgery. Gastrointestinal side effects played a
minor role in determining overall patient satisfaction.
The baseline self-reported HRQOL was very poor and
lower than the national norms in our series, as well in
several other studies involving morbidly obese candidates
for bariatric surgery [8,9,12–16]. In the first year after sur-
gery, we confirmed the highly significant rapid improve-
ment in HRQOL observed in previous studies of LAGB
[7–11]. Most of the improvement was seen in the first
months after the procedure, but a small additional increment
was also observed in the second postoperative semester. At
the end of our observation period, the mean values for all 8
subscales of the SF-36 questionnaire were comparable to
the Italian national norms (Fig. 2). Improvements in
HRQOL were substantial and very consistent between pa-
tients, with90% of participants showing better physical or
mental HRQOL. Patients with the most impaired levels of
HRQOL at baseline had the greater improvements of
HRQOL after surgery. The role of the degree of weight loss
on HRQOL changes after LAGB has been examined in
several studies. Dixon et al. [7] analyzed the SF-36 data
from 218 LAGB patients with paired preoperative and
1-year scores and demonstrated that the %EWL at 1 year
was of little predictive value for improved HRQOL. Nguyen
et al. [9], in a prospective randomized trial comparing gas-
tric bypass and gastric banding, found an equivalent im-
provement of HRQOL in the first year after the 2 proce-
dures, despite greater weight loss after gastric bypass.
Similar results were reported by a study comparing LAGB
and laparoscopic sleeve gastrectomy [10]. In our study, the
%EWL in the first year after LAGB was only moderately
related to improvements in the physical and mental sum-
mary scores of SF-36. Thus, we can conclude that highly
successful weight loss seems to have a little role in predict-
ing greater patient satisfaction after LAGB. If this is the
case, what other factors might be involved? Dixon et al. [7]
reported a role of preoperative co-morbidities in predicting
the improvement in HRQOL after LAGB. In our studies, we
did not observed any relationship between preoperative co-
morbidities or the resolution of co-morbidites after surgery
and the magnitude of HRQOL improvements. However,
266 V. Pilone et al. / Surgery for Obesity and Related Diseases 8 (2012) 260–268this might have resulted from the relatively low burden of
co-morbidities observed in our series at baseline.
The analysis of prospectively collected hunger and sati-
ety questionnaires demonstrated that patients in our study
had increased satiety after a standard meal and, more sur-
prisingly, reduced hunger in the morning after LAGB.
These subjective reports might well have been influenced by
a placebo effect. However, significantly greater fasting and
postprandial satiety levels have been previously demon-
strated in a randomized blind crossover study of LAGB
patients with optimal or reduced restriction [37]. Plasma
insulin, ghrelin, and leptin levels appeared unrelated to the
prolonged satiety observed by LAGB patients with optimal
restriction and displayed orexigenic compensatory changes
[37]. Whatever the mechanisms involved, our patients
graded as high (8 on a 0–10 scale) the self-perceived effect
of the banding on their caloric intake, and we found a
significant association between the self-perceived effect of
the banding and satiety after a meal and hunger in the
morning. More surprisingly, both satiety after a meal and
the self-perceived effect of banding on caloric intake were
positive independent predictors of the changes in the phys-
ical and mental components of HRQOL observed after
surgery. We might hypothesize that the help the patients
received from the LAGB in controlling eating behavior and
caloric intake should be important in determining the sub-
jective overall satisfaction of the patients with their proce-
dure.
Since the very beginning of its use in clinical practice,
gastric banding has been associated with the emergence of
some gastrointestinal side effects, with the most frequent
represented by episodes of food regurgitation during meals.
Busetto et al. [34] analyzed the eating patterns in the first
year after surgery of 80 morbidly obese patients undergoing
gastric banding with open surgical access from 1992 to
1994. They first reported a high frequency of food regurgi-
tation, with 11.5% of the patients having 20 episodes in
the last month and an additional 21.7% having 5–20 epi-
sodes. Such a high vomiting frequency played a significant
role in determining the global outcome, forcing the patients
to avoid solid foods and to switch to the consumption of soft
highly caloric processed foods [34]. The introduction of
more modern bands adapted to the laparoscopic approach
and the implementation of a more prudent strategy for
postoperative band adjustments, might have permitted a
reduction in vomiting frequency after surgery. However, in
a recent cross-sectional analysis of 323 patients treated with
LAGB from 2003 to 2007, Burton et al. [24] reported 9% of
patients with daily food regurgitation and an additional 23%
of patients having regurgitation more frequently than once
per week. The inability to consume a range of foods because
of the regurgitation was cited in their study as the most
troublesome symptom or problem after surgery by 66% of
patients [24]. A lower frequency of food regurgitation was
observed in our study, with only 4.0% of patients havingdaily food regurgitation and an additional 11.9% having
5–20 monthly episodes. This might be partly attributed to
the use in all patients of a large-volume low-pressure band
with a wider adjustability range, because all band adjust-
ments in our study were performed under radiologic guid-
ance and control, or because of other unknown factors.
Additionally, and in accordance with previous reports [24],
we confirmed a low frequency of other gastrointestinal
symptoms after surgery, reflux in particular. Moreover, ep-
isodes of gastric pyrosis did not seem to be increased after
surgery. The role of gastrointestinal side effects in deter-
mining overall patient satisfaction has been reported to be
marginal in a cross-sectional analysis of obese subjects
treated with LAGB [24]. In our study, we prospectively
confirmed no relationship between gastrointestinal symp-
toms (dysphagia, reflux, food regurgitation, and pyrosis)
and the changes in HRQOL observed after surgery. In
summary, the frequency of gastrointestinal side effects was
low, and their occurrence had little effect on patient satis-
faction after surgery. This observation has been attributed to
the fact that patients undergoing LAGB might be prepared
to accept some adverse symptoms as the price to pay for
successful weight loss and food control [34].
Our study had several methodologic limitations that
should be remembered in the interpretation of the results.
The total number of follow-up visits in the first year of our
study was 4, and this relatively low number of follow-up
contacts might have had a negative effect on excess weight
loss, which was lower than that reported in other studies
[1–3]. The diagnosis of physical co-morbidities at baseline
and after surgery was based on very simple clinical criteria,
and co-morbidities have been simple classified in the GILB-
PLUS database as present or absent, irrespective of their
clinical severity. Therefore, the effects of co-morbidities on
HRQOL changes could have been attenuated by some de-
gree of missing the diagnosis or by the absence of a more
precise staging of co-morbidity severity. The presence of
depression and eating behavior disorders was also tested
before surgery with the use of an unstructured clinical
evaluation and without the application of any formal testing.
Some gastrointestinal side effects observed after surgery
(dysphagia and reflux) were also simply categorized as
absent or present and not graded with the use of the more
sophisticated scores applied in some recent reports [24]. The
definition of dysphagia adopted in our gastrointestinal
symptom questionnaire as difficultly in swallowing any type
of food might have produced an underestimation of this
symptom in our patients. Finally, in the present study, the
HRQOL changes were analyzed using a single instrument,
the SF-36 questionnaire. Obesity-specific instruments, such
as the Impact of Weight on Quality of Life questionnaire or
others, might be more sensitive to the effects of weight and
weight-related problems on self-perceived well-being and,
therefore, more sensitive to detecting the changes in
HRQOL after weight loss [20,21]. These limitations in
[[
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count in evaluating the results of our study, but these should
be partly compensated for by the rather high number of
participants and the multicenter design.
Conclusion
Our results have confirmed that HRQOL was severely
impaired in morbid obese candidates to LAGB but substan-
tially improved in the first year after surgery, particularly in
patients with lower baseline HRQOL levels. A high self-
perceived efficacy of the LAGB in eating control was at
least equally important as a good weight loss in determining
HRQOL changes. The sustainability of these effects over
time remains debated, and it will be specifically investigated
in the continuation of the ongoing GILBPLUS 3-year ob-
servational study on the changes in HRQOL in patients
undergoing LAGB.
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The activities of the Italian Group for Lap-Band (Gruppo
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participating investigators or institutions received direct
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Appendix
The following investigators and institutions participated
in the Italian Group of Lap-Band (Gruppo Italiano Lap-band
[GILBPLUS]) prospective 3-year observational study on
the changes of HRQOL in patients treated with LAGB. The
number of cases enrolled at each center is provided in
parentheses: A. M. Schettino, C. Pari, V. Pasini, U. O. di
Chirurgia, Casa di Cura Malatesta Novello, Cesena (52); V.
Pilone, P. Forestieri, S. Tramontano, Dipartimento di Chiru-
rgia Generale, Oncologica, Bariatrica e Videoassistita, Uni-
versità degli Studi Federico II, Napoli (45); F. Furbetta, S.
Gennai, N. Furbetta, U. O. di Chirurgia, Casa di Cura
Leonardo, Empoli (43); E. Mozzi, E. Lattuada, M. Zappa,
Cattedra di Chirurgia Generale, Università degli Studi di
Milano–Fondazione IRCCS Ca’Granda Ospedale Maggiore
Policlinico, Milano (41); A. Di Maro, S. Civitelli, Istituto
Ninetta Rosano, Clinica Tricarico, Belvedere Marittimo
(32); C. Giardiello, V. Antognozzi, U. O. C. Chirurgia
Generale, d’Urgenza e Metabolica, Centro per il trattamento
Obesità, Presidio Ospedaliero Pineta, Grande, Castelvol-
turno (30); M. Battistoni, M. Genna II Chirurgia Generale,
Servizio di Chirurgia dell’Obesità, Azienda Ospedaliera
Universitaria Integrata, Verona (26); A. Gardinazzi, M. Ba-zzana, Ospedale Generale Classificato di Zona S. Orsola,
Fondazione Poliambulanza, Brescia (24); N. Perrotta, A.
Cappiello, UOC di Chirurgia Generale, Ospedale di Villa
d’Agri, Azienda Sanitaria di Potenza (22); G. Micheletto, E.
Moroni, Cattedra di Chirurgia Generale Università degli
Studi di Milano–UOC di Chirurgia Generale, Istituto
Clinico Sant’Ambrogio, Milano (20).
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